In Q4 of fiscal 2023, the quarter ended Dec 31, 2023, NP Life Sciences Health Industry Group Inc. reported revenue of $10,007, down 78.3% from the same quarter a year earlier. It recorded a net loss of $15,355. The operating loss came to $35,862, an operating margin of -358.4%. Diluted earnings per share were -$0.00.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.
| Line |
Q4 FY2023
Dec 31, 2023
|
Q3 FY2023
Sep 30, 2023
|
Q2 FY2023
Jun 30, 2023
|
Q1 FY2023
Mar 31, 2023
|
Q4 FY2022
Dec 31, 2022
|
Q3 FY2022
Sep 30, 2022
|
Q2 FY2022
Jun 30, 2022
|
Q1 FY2022
Mar 31, 2022
|
|---|---|---|---|---|---|---|---|---|
| Revenue |
0
-78.3%
|
0
-57.3%
|
0
+614.9%
|
0
|
0
+130.2%
|
0
|
0
|
—
|
| Selling, general and administrative |
0
+55.9%
|
0
+18.3%
|
0
+156.8%
|
0
-7.5%
|
0
+980.4%
|
0
+122.9%
|
0
-73.6%
|
0
+28.2%
|
| Operating income |
-0
-316.0%
|
-0
-588.3%
|
0
+6528.8%
|
0
+103.9%
|
0
-48.6%
|
-0
+73.9%
|
0
+102.0%
|
-0
-28.2%
|
| Pretax income |
-0
|
-0
-588.3%
|
—
|
0
+103.9%
|
—
|
-0
+73.9%
|
0
+102.0%
|
-0
-28.3%
|
| Income tax |
-0
|
-0
|
0
|
—
|
—
|
—
|
—
|
—
|
| Net income |
-0
-192.5%
|
-0
-592.5%
|
0
+6504.4%
|
0
+103.9%
|
0
-48.6%
|
-0
+73.9%
|
0
+102.0%
|
-0
-28.3%
|
| Basic EPS |
-0.00
-192.5%
|
-0.00
-592.5%
|
0.00
+6504.4%
|
0.00
|
0.00
|
-0.00
|
0.00
|
0.00
|
| Diluted EPS |
-0.00
|
-0.00
|
0.00
|
—
|
—
|
—
|
—
|
—
|
| Weighted average shares, basic |
43
+0.0%
|
43
+0.0%
|
43
+0.0%
|
43
+0.0%
|
43
|
43
|
43
|
43
|
| Weighted average shares, diluted |
43
|
43
|
43
|
—
|
—
|
—
|
—
|
—
|
| Margins | ||||||||
| Operating margin |
-358.37%
|
-213.79%
|
66.66%
|
4.08%
|
36.07%
|
-13.27%
|
7.19%
|
—
|
| Pretax margin |
-364.81%
|
-213.79%
|
—
|
4.07%
|
—
|
-13.27%
|
7.19%
|
—
|
| Profit margin |
-153.44%
|
-215.07%
|
66.48%
|
4.07%
|
36.07%
|
-13.27%
|
7.20%
|
—
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Services-Educational Services (SIC 8200)
- Listed as
- ACAT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Danville, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1781726
- Former names
- GJ Culture Group US, Inc. (until Sep 29, 2022)
Other Services-Educational Services companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.